Guizhou Xinbang Pharmaceutical Co.,Ltd. (贵州信邦制药股份有限公司) (002390.SZ) reported a net profit of 191.6
Guizhou Xinbang Pharmaceutical Co.,Ltd. (贵州信邦制药股份有限公司) (002390.SZ) reported a net profit of 62.6
热评:
Guizhou Xinbang Pharmaceutical Co.,Ltd. (贵州信邦制药股份有限公司) (002390.SZ) reported a net profit of 268.4
(600562.SH),增持了复星医药(600136.SH)、信邦制药(002393.SZ)等,减持了华润三九、同仁堂(600085.SH)、人福医药、羚锐制药(600285.SH)等多家药企。截至三季
Guizhou Xinbang Pharmaceutical Co.,Ltd. (贵州信邦制药股份有限公司) (002390.SZ) reported a net profit of 276.7
Guizhou Xinbang Pharmaceutical Co.,Ltd. (贵州信邦制药股份有限公司) (002390.SZ) reported a net profit of 156
Guizhou Xinbang Pharmaceutical Co.,Ltd. (贵州信邦制药股份有限公司) (002390.SZ) reported a net profit of 79.5
Guizhou Xinbang Pharmaceutical Co.,Ltd. (贵州信邦制药股份有限公司) (002390.SZ) reported a net profit of 242.6
Guizhou Xinbang Pharmaceutical Co.,Ltd. (贵州信邦制药股份有限公司) (002390.SZ) reported a net profit of 158.4
图片
视频
Guizhou Xinbang Pharmaceutical Co.,Ltd. (贵州信邦制药股份有限公司) (002390.SZ) reported a net profit of 62.6
热评:
Guizhou Xinbang Pharmaceutical Co.,Ltd. (贵州信邦制药股份有限公司) (002390.SZ) reported a net profit of 268.4
热评:
(600562.SH),增持了复星医药(600136.SH)、信邦制药(002393.SZ)等,减持了华润三九、同仁堂(600085.SH)、人福医药、羚锐制药(600285.SH)等多家药企。截至三季
热评:
Guizhou Xinbang Pharmaceutical Co.,Ltd. (贵州信邦制药股份有限公司) (002390.SZ) reported a net profit of 276.7
热评:
Guizhou Xinbang Pharmaceutical Co.,Ltd. (贵州信邦制药股份有限公司) (002390.SZ) reported a net profit of 156
热评:
Guizhou Xinbang Pharmaceutical Co.,Ltd. (贵州信邦制药股份有限公司) (002390.SZ) reported a net profit of 79.5
热评:
Guizhou Xinbang Pharmaceutical Co.,Ltd. (贵州信邦制药股份有限公司) (002390.SZ) reported a net profit of 242.6
热评:
Guizhou Xinbang Pharmaceutical Co.,Ltd. (贵州信邦制药股份有限公司) (002390.SZ) reported a net profit of 158.4
热评: